查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946614

基於NGS的RNA定序全球市場報告（2026年）

NGS-Based RNA-Sequencing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基於次世代定序（NGS）的RNA定序市場發展迅速，預計將從2025年的42億美元成長到2026年的52.7億美元，複合年成長率（CAGR）為25.3%。過去幾年的成長可歸因於基因組研究舉措的擴展、定序技術成本的下降、RNA測序在學術研究中的日益普及、先進定序平台的廣泛應用以及生物資訊學能力的提升。

基於次世代定序(NGS) 的 RNA定序市場預計將在未來幾年呈指數級成長，到 2030 年將達到 127.3 億美元，複合年成長率 (CAGR) 為 24.7%。預測期內的成長要素包括：RNA 定序在臨床診斷中的應用日益廣泛、精準醫療投資不斷增加、藥物研發應用不斷擴展、對整合資料分析解決方案的需求不斷成長，以及對多體學研究的日益重視。預測期內的關鍵趨勢包括：高通量 RNA定序平台的日益普及、對單細胞 RNA定序的需求不斷成長、基於雲端的生物資訊分析應用日益廣泛、轉錄組學在精準醫療中的應用不斷擴展，以及對數據準確性和擴充性的日益關注。

預計不斷擴張的製藥業將推動基於次世代定序（NGS）的RNA定序市場持續成長。製藥業涵蓋公共和私營機構所進行的藥品研發和生產活動。在該領域，基於NGS的RNA定序被廣泛用於進行全面的基因表現分析、識別和檢驗潛在的藥物標靶、評估藥物反應以及深入了解疾病生物學，從而支持更高效、數據驅動的藥物發現和開發。例如，根據歐洲製藥工業協會聯合會（EFPIA）的數據，截至2024年11月，預計北美將佔2024年全球藥品銷售額的54.8%，而歐洲佔22.7%。因此，製藥業的擴張顯著促進了基於NGS的RNA定序市場的成長。

基於新一代定序（NGS）技術的RNA定序市場中的主要企業正致力於開發創新產品，例如先進的小RNA定序試劑盒，以簡化工作流程並提高RNA表現研究的準確性和效率。這些先進的小RNA定序試劑盒是新一代樣品製備方案，旨在精確捕獲和定序小RNA分子，從而幫助研究人員縮短處理時間，減少接頭二聚體等技術誤差，並產生更一致、更可重複的表達數據。例如，2025年10月，總部位於奧地利的生技公司Lexogen發布了miRVEL Profiling Small RNA-Seq Library Prep Kit，旨在簡化和最佳化小RNA研究工作流程。該試劑盒可在7小時內製備定序就緒的文庫，操作時間極短，並透過先進的接頭封閉技術最大限度地減少接頭二聚體的形成。此外，該試劑盒在各種起始量下均表現出高度可重複的性能，並整合了一個8核苷酸特異性雙索引，用於精確的多重定序和讀段分配。 miRVEL 分析試劑盒支援多種應用，包括RNA干擾研究、宿主防禦機制研究以及植物和農業中的小 RNA 分析。它還相容於 Lexogen 的 SPLIT RNA 萃取試劑盒和 TraPR 小 RNA 富集系統，為小 RNA定序提供全面的端到端解決方案。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球基於NGS的RNA定序市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 高通量RNA定序平台的應用日益廣泛
    • 單細胞RNA定序需求不斷成長
    • 擴大基於雲端的生物資訊分析的應用
    • 拓展轉錄組學在精準醫學的應用
    • 更加重視數據準確性和擴充性

第5章 終端用戶產業市場分析

  • 研究和學術機構
  • 醫院和診所
  • 製藥公司
  • 生技公司
  • 基因組學服務供應商

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球基於NGS的RNA定序市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球基於NGS的RNA定序市場規模、比較及成長率分析
  • 全球基於NGS的RNA定序市場表現：規模與成長，2020-2025年
  • 全球基於NGS的RNA定序市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按產品和服務分類
  • 樣品製備產品、定序平台和耗材、定序服務、數據分析、儲存和管理
  • 透過技術
  • 合成定定序、離子半導體定序、單分子即時定序、奈米孔定序
  • 透過使用
  • 表達譜分析、小RNA定序和從頭轉錄組組裝
  • 最終用戶
  • 研究和學術機構、製藥和生物技術公司以及其他最終用戶
  • 依類型細分：樣品製備產品
  • RNA萃取試劑盒、文庫建構試劑盒、逆轉錄試劑盒、品管試劑
  • 按類型細分：定序平台和耗材
  • 定序設備、定序耗材
  • 按類型細分：定序服務
  • 合定序服務、客製化樣品製備服務、諮詢和實驗設計服務
  • 按類型細分：資料分析、儲存和管理
  • 生物資訊軟體、數據分析服務、基於雲端的數據儲存解決方案和數據管理平台

第10章 區域與國家分析

  • 全球基於NGS的RNA定序市場：按地區分類，實際結果和預測，2020-2025年，2025-2030年預測，2035年預測
  • 全球基於NGS的RNA定序市場：依國家分類，實際結果與預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 基於NGS的RNA定序市場：競爭格局與市場佔有率，2024年
  • 基於NGS的RNA定序市場：公司估值矩陣
  • 基於新一代定序技術的RNA定序市場：公司概況
    • Illumina Inc.
    • Thermo Fisher Scientific Inc.
    • Oxford Nanopore Technologies Ltd.
    • Agilent Technologies Inc.
    • BGI Group

第37章：其他領先和創新企業

  • QIAGEN NV, Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear BV, Otogenetics Corporation

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 基於NGS的RNA定序市場展望（2030年）：提供新機會的國家
  • 基於NGS的RNA定序市場展望（2030年）：新興細分市場機會
  • 基於新一代定序技術的RNA定序市場展望（2030年）：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MNBRS01_G26Q1

NGS-based RNA-sequencing is a technique employed to identify and quantify the amount of ribonucleic acid (RNA) present in a biological sample at a specific moment, utilizing next-generation sequencing (NGS). Next-generation sequencing, characterized by massively parallel sequencing technology, offers exceptionally high throughput, scalability, and speed, allowing for the determination of nucleotide sequences in whole genomes or specific DNA/RNA segments.

The primary products and services associated with NGS-based RNA sequencing include sample preparation products, sequencing platforms and consumables, sequencing services, and data analysis, storage, & management. Sample preparation products facilitate the adherence of DNA or RNA to the sequencing flowcell, enabling sample identification. The sample preparation process involves converting nucleic acid mixtures from biological samples into various libraries, preparing them for NGS technologies. Technologies involved in NGS encompass sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. These sequencing methods find application in expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, variant calling, and transcriptome epigenetics. NGS-based RNA-sequencing is utilized by a range of end users, including research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other entities in the scientific community.

Tariffs are impacting the NGS-based RNA-sequencing market by increasing costs of imported sequencing instruments, reagents, consumables, and data storage infrastructure. Research laboratories and biotechnology companies in North America and Europe are most affected due to dependence on imported platforms, while Asia-Pacific faces cost pressure on sequencing services. These tariffs are increasing operational costs and slowing technology upgrades. However, they are also encouraging domestic instrument manufacturing, regional reagent production, and development of localized sequencing service providers.

The ngs-based rna-sequencing market research report is one of a series of new reports from The Business Research Company that provides ngs-based rna-sequencing market statistics, including ngs-based rna-sequencing industry global market size, regional shares, competitors with a ngs-based rna-sequencing market share, detailed ngs-based rna-sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the ngs-based rna-sequencing industry. This ngs-based rna-sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ngs-based rna-sequencing market size has grown exponentially in recent years. It will grow from $4.2 billion in 2025 to $5.27 billion in 2026 at a compound annual growth rate (CAGR) of 25.3%. The growth in the historic period can be attributed to expansion of genomic research initiatives, declining cost of sequencing technologies, increased use of rna-seq in academic research, availability of advanced sequencing platforms, growth of bioinformatics capabilities.

The ngs-based rna-sequencing market size is expected to see exponential growth in the next few years. It will grow to $12.73 billion in 2030 at a compound annual growth rate (CAGR) of 24.7%. The growth in the forecast period can be attributed to increasing adoption of rna sequencing in clinical diagnostics, rising investments in precision medicine, expansion of pharmaceutical research applications, growing demand for integrated data analysis solutions, increasing focus on multi-omics research. Major trends in the forecast period include increasing adoption of high-throughput rna sequencing platforms, rising demand for single-cell rna sequencing, growing use of cloud-based bioinformatics analysis, expansion of transcriptomics in precision medicine, enhanced focus on data accuracy and scalability.

The expanding pharmaceutical industry is anticipated to support the continued growth of the NGS-based RNA-sequencing market. The pharmaceutical industry encompasses the research, development, and manufacturing of drugs and medicines by both public and private organizations. Within this sector, NGS-based RNA-sequencing is widely used to perform comprehensive gene expression analysis, identify and validate potential drug targets, evaluate drug responses, and gain deeper insights into disease biology, thereby supporting more efficient and data-driven drug discovery and development. For example, in November 2024, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, North America accounted for 54.8% of global pharmaceutical sales in 2024, while Europe represented 22.7%. As a result, the expansion of the pharmaceutical industry is contributing significantly to the growth of the NGS-based RNA-sequencing market.

Leading companies active in the NGS-based RNA-sequencing market are increasingly concentrating on the development of innovative offerings such as advanced small RNA-sequencing kits to simplify workflows and enhance the precision and efficiency of RNA expression studies. These advanced small RNA-seq kits are next-generation library preparation solutions engineered to accurately capture and sequence small RNA molecules, enabling researchers to shorten processing times, reduce technical artifacts such as adapter dimers, and generate more consistent and reproducible expression data. For instance, in October 2025, Lexogen, an Austria-based biotechnology company, introduced the miRVEL Profiling Small RNA-Seq Library Prep Kit, which is designed to streamline and optimize small RNA research workflows. The kit enables the preparation of ready-to-sequence libraries in less than seven hours with limited hands-on time, incorporates advanced adapter-blocking technology to minimize adapter dimer formation, delivers reproducible performance across a wide range of input amounts, and includes integrated 8-nucleotide unique dual indices for accurate multiplexing and read assignment. The miRVEL Profiling Kit supports diverse applications such as RNA interference research, studies of host defense mechanisms, and plant and agricultural small RNA analysis, and is compatible with Lexogen's SPLIT RNA extraction kits and TraPR small RNA enrichment system, offering a comprehensive end-to-end solution for small RNA sequencing.

In November 2024, ARCHIMED SAS, a France-based private equity firm, acquired SeqCenter LLC for an undisclosed consideration. Through this acquisition, ARCHIMED sought to enhance its diagnostics and life-science tools portfolio by expanding SeqCenter's next-generation sequencing capabilities, accelerating international growth, and promoting innovation in high-throughput and cost-efficient DNA and RNA sequencing services. SeqCenter LLC is a United States-based genetic sequencing services provider specializing in fast, reliable, and affordable DNA and RNA sequencing solutions for use across research, biotechnology, diagnostics, agriculture, and environmental health applications.

Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ngs-based rna-sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The NGS-based RNA-sequencing market includes revenues earned by ribosomal RNA (rRNA), transfer RNA (tRNA), long ncRNA and many smaller ncRNAs such as microRNA. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

NGS-Based RNA-Sequencing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ngs-based rna-sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ngs-based rna-sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ngs-based rna-sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product And Service: Sample Preparation Products; Sequencing Platforms and Consumables; Sequencing Services; Data Analysis, Storage, and Management
  • 2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing
  • 3) By Application: Expression Profiling Analysis; Small RNA Sequencing; De Novo Transcriptome Assembly
  • 4) By End User: Research & Academia; Pharmaceutical & Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Sample Preparation Products: RNA Extraction Kits; Library Preparation Kits; Reverse Transcription Kits; Quality Control Reagents
  • 2) By Sequencing Platforms And Consumables: Sequencing Instruments; Sequencing Consumables
  • 3) By Sequencing Services: Contract Sequencing Services; Custom Library Preparation Services; Consultation And Experimental Design Services
  • 4) By Data Analysis, Storage, And Management: Bioinformatics Software; Data Analysis Services; Cloud-Based Data Storage Solutions; Data Management Platforms
  • Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Oxford Nanopore Technologies Ltd.; Agilent Technologies Inc.; BGI Group; QIAGEN N.V.; Eurofins Scientific SE; Bio-Rad Laboratories Inc.; F. Hoffmann-La Roche Ltd.; Takara Bio Inc.; GENEWIZ Inc.; Novogene Corporation; Macrogen Inc.; Zymo Research Corp.; Lexogen GmbH; Partek Incorporated; GATC Biotech AG; Genohub LLC; BaseClear B.V.; Otogenetics Corporation; SeqLL LLC; GenXPro GmbH; Genotypic Technology Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. NGS-Based RNA-Sequencing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global NGS-Based RNA-Sequencing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. NGS-Based RNA-Sequencing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global NGS-Based RNA-Sequencing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of High-Throughput Rna Sequencing Platforms
    • 4.2.2 Rising Demand For Single-Cell Rna Sequencing
    • 4.2.3 Growing Use Of Cloud-Based Bioinformatics Analysis
    • 4.2.4 Expansion Of Transcriptomics In Precision Medicine
    • 4.2.5 Enhanced Focus On Data Accuracy And Scalability

5. NGS-Based RNA-Sequencing Market Analysis Of End Use Industries

  • 5.1 Research And Academia
  • 5.2 Hospitals And Clinics
  • 5.3 Pharmaceutical Companies
  • 5.4 Biotechnology Companies
  • 5.5 Genomics Service Providers

6. NGS-Based RNA-Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global NGS-Based RNA-Sequencing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global NGS-Based RNA-Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global NGS-Based RNA-Sequencing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global NGS-Based RNA-Sequencing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global NGS-Based RNA-Sequencing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global NGS-Based RNA-Sequencing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. NGS-Based RNA-Sequencing Market Segmentation

  • 9.1. Global NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management
  • 9.2. Global NGS-Based RNA-Sequencing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
  • 9.3. Global NGS-Based RNA-Sequencing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly
  • 9.4. Global NGS-Based RNA-Sequencing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Research & Academia, Pharmaceutical & Biotechnology Companies, Other End Users
  • 9.5. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sample Preparation Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents
  • 9.6. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Platforms And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sequencing Instruments, Sequencing Consumables
  • 9.7. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Sequencing Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services
  • 9.8. Global NGS-Based RNA-Sequencing Market, Sub-Segmentation Of Data Analysis, Storage, And Management, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

10. NGS-Based RNA-Sequencing Market Regional And Country Analysis

  • 10.1. Global NGS-Based RNA-Sequencing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global NGS-Based RNA-Sequencing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific NGS-Based RNA-Sequencing Market

  • 11.1. Asia-Pacific NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China NGS-Based RNA-Sequencing Market

  • 12.1. China NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India NGS-Based RNA-Sequencing Market

  • 13.1. India NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan NGS-Based RNA-Sequencing Market

  • 14.1. Japan NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia NGS-Based RNA-Sequencing Market

  • 15.1. Australia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia NGS-Based RNA-Sequencing Market

  • 16.1. Indonesia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea NGS-Based RNA-Sequencing Market

  • 17.1. South Korea NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan NGS-Based RNA-Sequencing Market

  • 18.1. Taiwan NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia NGS-Based RNA-Sequencing Market

  • 19.1. South East Asia NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe NGS-Based RNA-Sequencing Market

  • 20.1. Western Europe NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK NGS-Based RNA-Sequencing Market

  • 21.1. UK NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany NGS-Based RNA-Sequencing Market

  • 22.1. Germany NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France NGS-Based RNA-Sequencing Market

  • 23.1. France NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy NGS-Based RNA-Sequencing Market

  • 24.1. Italy NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain NGS-Based RNA-Sequencing Market

  • 25.1. Spain NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe NGS-Based RNA-Sequencing Market

  • 26.1. Eastern Europe NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia NGS-Based RNA-Sequencing Market

  • 27.1. Russia NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America NGS-Based RNA-Sequencing Market

  • 28.1. North America NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA NGS-Based RNA-Sequencing Market

  • 29.1. USA NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada NGS-Based RNA-Sequencing Market

  • 30.1. Canada NGS-Based RNA-Sequencing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America NGS-Based RNA-Sequencing Market

  • 31.1. South America NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil NGS-Based RNA-Sequencing Market

  • 32.1. Brazil NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East NGS-Based RNA-Sequencing Market

  • 33.1. Middle East NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa NGS-Based RNA-Sequencing Market

  • 34.1. Africa NGS-Based RNA-Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa NGS-Based RNA-Sequencing Market, Segmentation By Product And Service, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. NGS-Based RNA-Sequencing Market Regulatory and Investment Landscape

36. NGS-Based RNA-Sequencing Market Competitive Landscape And Company Profiles

  • 36.1. NGS-Based RNA-Sequencing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. NGS-Based RNA-Sequencing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. NGS-Based RNA-Sequencing Market Company Profiles
    • 36.3.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Oxford Nanopore Technologies Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. BGI Group Overview, Products and Services, Strategy and Financial Analysis

37. NGS-Based RNA-Sequencing Market Other Major And Innovative Companies

  • QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation

38. Global NGS-Based RNA-Sequencing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The NGS-Based RNA-Sequencing Market

40. NGS-Based RNA-Sequencing Market High Potential Countries, Segments and Strategies

  • 40.1 NGS-Based RNA-Sequencing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 NGS-Based RNA-Sequencing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 NGS-Based RNA-Sequencing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer